Inflammation in Depression and the Potential for Anti-Inflammatory Treatment, Current Neuropharmacology, vol.14, issue.7, pp.732-742, 2016. ,
Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects, Neuropsychopharmacology, vol.28, issue.7, pp.1328-1335, 2003. ,
Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims, Archives of General Psychiatry, vol.45, issue.6, p.577, 1988. ,
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress, Nature Neuroscience, vol.6, issue.10, pp.1100-1107, 2003. ,
The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease, International Journal of Molecular Sciences, vol.18, issue.12, p.2614, 2017. ,
Effet antidépresseur de la kétamine : revue de la littérature sur l?utilisation de la kétamine dans la dépression, L'Encéphale, vol.40, issue.1, pp.15-23, 2014. ,
Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study, Psychiatry Research, vol.269, pp.207-211, 2018. ,
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression, American Journal of Psychiatry, vol.150, issue.4, pp.656-657, 1993. ,
Effects of electroconvulsive therapy on the CRH-ACTHcortisol system in melancholic depression: preliminary findings. Psychopharmacol, Bull, vol.30, pp.489-494, 1994. ,
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects, American Journal of Psychiatry, vol.153, issue.1, pp.93-99, 1996. ,
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biological Psychiatry, vol.49, issue.5, pp.391-404, 2001. ,
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat. Genet, vol.36, pp.1319-1325, 2004. ,
Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression, Biological Psychiatry, vol.59, issue.8, pp.681-688, 2006. ,
Genetic predictors of response to antidepressants in the GENDEP project, The Pharmacogenomics Journal, vol.9, issue.4, pp.225-233, 2009. ,
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans, Molecular Psychiatry, vol.9, issue.12, pp.1075-1082, 2004. ,
Association of Polymorphisms in Genes Regulating the Corticotropin-Releasing Factor System With Antidepressant Treatment Response, Archives of General Psychiatry, vol.67, issue.4, p.369, 2010. ,
Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years, Drugs, vol.77, issue.18, pp.1967-1986, 2017. ,
, Psychopharmacogenetics, Psychopharmacogenetics, 2006.
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors, Neuroscience, vol.69, issue.1, pp.89-98, 1995. ,
Tianeptine attenuates stress-induced morphological changes in the hippocampus, European Journal of Pharmacology, vol.222, issue.1, pp.157-162, 1992. ,
The atypical antidepressant and neurorestorative agent tianeptine is a ?-opioid receptor agonist, Translational Psychiatry, vol.4, issue.7, pp.e411-e411, 2014. ,
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor, Neuropsychopharmacology, vol.42, issue.10, pp.2052-2063, 2017. ,
Role of endogenous opioid system in the regulation of the stress response, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.25, issue.4, pp.729-741, 2001. ,
Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G, Neuropsychopharmacology, vol.40, issue.11, pp.2546-2554, 2015. ,
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation, Molecular Psychiatry, vol.15, issue.3, pp.237-249, 2009. ,
Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients, American Journal of Psychiatry, vol.165, issue.6, pp.731-739, 2008. ,
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysis, European Psychiatry, vol.28, issue.6, pp.362-371, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00794961
Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression, Psychiatry Research, vol.104, issue.3, pp.247-257, 2001. ,
Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study, BMC Psychiatry, vol.14, issue.1, p.220, 2014. ,
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment, Journal of Affective Disorders, vol.104, issue.1-3, pp.83-90, 2007. ,
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans, Molecular Psychiatry, vol.14, issue.12, pp.1105-1118, 2009. ,
Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder, The Pharmacogenomics Journal, vol.13, issue.3, pp.280-285, 2012. ,
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein, American Journal of Psychiatry, vol.175, issue.3, pp.251-261, 2018. ,
CRHR1 genotype and history of maltreatment predict cortisol reactivity to stress in adolescents, Psychoneuroendocrinology, vol.43, pp.71-80, 2014. ,
Stress-System Genes and Life Stress Predict Cortisol Levels and Amygdala and Hippocampal Volumes in Children, Neuropsychopharmacology, vol.39, issue.5, pp.1245-1253, 2013. ,
Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression, Translational Psychiatry, vol.8, issue.1, p.5, 2018. ,
Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults, Psychopharmacology, vol.227, issue.2, pp.231-241, 2012. ,
HPA axis genetic variation, cortisol and psychosis in major depression, Molecular Psychiatry, vol.19, issue.2, pp.220-227, 2013. ,
Interaction of Early Life Stress and Corticotropin-Releasing Hormone Receptor Gene: Effects on Working Memory, Biological Psychiatry, vol.76, issue.11, pp.888-894, 2014. ,
Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing, Molecular Psychiatry, vol.21, issue.6, pp.813-822, 2015. ,
Influence of Child Abuse on Adult Depression, Archives of General Psychiatry, vol.65, issue.2, p.190, 2008. ,
Protective Effect of CRHR1 Gene Variants on the Development of Adult Depression Following Childhood Maltreatment, Archives of General Psychiatry, vol.66, issue.9, p.978, 2009. ,
Interaction of Childhood Maltreatment with the Corticotropin-Releasing Hormone Receptor Gene: Effects on Hypothalamic-Pituitary-Adrenal Axis Reactivity, Biological Psychiatry, vol.66, issue.7, pp.681-685, 2009. ,
Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter, PLoS ONE, vol.8, issue.5, p.e63772, 2013. ,
Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter - revisited, Genes, Brain and Behavior, vol.15, issue.2, pp.209-220, 2016. ,
Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala, Nature, vol.537, issue.7618, pp.97-101, 2016. ,
Potentiation of ?-opioid receptor-mediated signaling by ketamine, Journal of Neurochemistry, vol.119, issue.2, pp.294-302, 2011. ,
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism, American Journal of Psychiatry, vol.175, issue.12, pp.1205-1215, 2018. ,